Suministro de Acoramidis (DOE) y Darolutamida (DOE)
TED · 507545-2026Award noticeawardedNo deadline given
Buyer
NameOSAKIDETZA - Servicio Vasco de Salud - Organización Central
CountryES
Published2026-07-22
Deadline—
Value
Estimated€11,921,232 · 11,921,232 EUR
Awarded€9,934,360 · 9,934,360 EUR
WinnerBAYER HISPANIA, S.L.
Who already wins at this buyer
Firms with recorded awards from OSAKIDETZA - Servicio Vasco de Salud - Organización Central in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| EDWARDS LIFESCIENCIES, S.L. | ABBOTT MEDICAL ESPAÑA SA | MEDTRONIC IBÉRICA, S.A. | BOSTON SCIENTIFIC IBÉRICA, S.A. | MERCÉ V. ELECTROMEDICINA, S.L. | PALEX MEDICAL | SAGITTAE MEDICAL S.L | SERMEBI 97 SL | 3 | €24,084,632 | 2026-07-13 |
| ASTRAZENECA FARMACEUTICA SPAIN, S.A. | 3 | €11,241,391 | 2026-06-03 |
| TAKEDA FARMACÉUTICA ESPAÑA, S.A. | 3 | €8,594,135 | 2026-07-21 |
| PFIZER S L | 3 | €3,078,902 | 2026-06-19 |
| PFIZER, S.L. | 3 | €950,419 | 2026-07-15 |
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
Suministro de Acoramidis (DOE) y Darolutamida (DOE)
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-05-04 | Suministro de Uroquinasa (DOE) y Natalizumab (DOE) | OSAKIDETZA - Servicio Vasco de Salud - Organización Central ES | 96% |
| 2026-05-28 | Suministro de Evolocumab (DOE) y Apremilast (DOE) | OSAKIDETZA - Servicio Vasco de Salud - Organización Central ES | 96% |
| 2026-05-19 | Suministro de Ustekinumab (DOE) y Rilpirivina (DOE) | OSAKIDETZA - Servicio Vasco de Salud - Organización Central ES | 96% |
| 2026-05-05 | Suministro de Lanadelumab (DOE) | OSAKIDETZA - Servicio Vasco de Salud - Organización Central ES | 96% |
| 2026-06-19 | Suministro de Somatropina (DOE) | OSAKIDETZA - Servicio Vasco de Salud - Organización Central ES | 96% |
| 2026-06-17 | Suministro de Axitinib (DOE) y Gemtuzumab ozogamicina (DOE) | OSAKIDETZA - Servicio Vasco de Salud - Organización Central ES | 96% |